Latest news with #Bpifrance
Reuters
13 hours ago
- Business
- Reuters
France tightens grip on Eutelsat through 1.35 bln-euro shares sale
PARIS, June 19 (Reuters) - The French state will become Eutelsat's ( opens new tab top shareholder following a 1.35 billion-euro ($1.55 billion) capital increase aimed at helping the satellite company better compete with Elon Musk's Starlink, the finance ministry said on Thursday. The capital injection will deliver a shot in the arm to debt-laden Eutelsat, which has garnered unprecedented attention this year from European governments looking for alternatives to compete with Elon Musk's Starlink. France's state shareholding agency will inject 717 million euros, or more than half of the sum, into the company, the ministry said. The agency will also acquire the stake held by France's state-owned investment bank Bpifrance in Eutelsat as part of the company, a government official said, bringing France's total stake to 29.99%. "The French government is proud to support Eutelsat. By participating in its capital increase, we are supporting a decisive stage in its development. Satellite connectivity is a strategic issue for our industrial and digital sovereignty," Finance Minister Eric Lombard said. ($1 = 0.8721 euros)
Yahoo
3 days ago
- Business
- Yahoo
Winner of the 'Biotherapies and Bioproduction' call for projects under the France 2030 plan, EVerZom receives €3 million in government funding to industrialize its exosome bioproduction technology
Winner of the 'Biotherapies and Bioproduction' call for projects under the France 2030 plan, EVerZom receives €3 million in government funding to industrialize its exosome bioproduction technology Paris, June 17, 2025 – EVerZom, a French biopharmaceutical company pioneering exosome-based therapies for regenerative medicine applications, has announced it has received €3 million in funding as part of the France 2030 plan, through the 'Biotherapies and Bioproduction of Innovative Therapies' call for projects, operated by Bpifrance on behalf of the French government. This financial support will enable the company to accelerate the industrialization of its exosome bioproduction platform to develop its proprietary and co-developed drug candidates. Accelerating the transition to late-stage clinical production and commercialization This funding marks a key step in the company's industrial scale-up. It will notably allow for the scale-up of its exosome bioproduction technology in 50L GMP bioreactors, reaching a production level compatible with late-stage clinical phases and market launch. 'The French government 's support through the France 2030 'Biotherapies and Bioproduction' call is a strong recognition of our technology and industrial ambition. Thanks to this funding, we will secure a robust and scalable bioproduction process, which is essential to advance through late-stage clinical phases and prepare the market entry of our future proprietary or co-developed treatments,' said Jeanne Volatron, CEO of EVerZom. Exosomes at the heart of the development of promising new biotherapies Exosomes are tiny biological vesicles (30 to 150 nanometers) naturally secreted by cells. They play a key role in intercellular communication, transporting proteins, messenger RNAs, and other functional biomolecules between cells. EVerZom leverages exosomes derived from mesenchymal stem cells, known for their regenerative and immunomodulatory properties. Compared to the cells themselves, exosomes offer numerous advantages: increased stability, reduced variability, enhanced patient safety, and simplified logistics (direct hospital storage and immediate availability). EVerGel, EVerZom's first drug candidate for Crohn's disease EVerZom's flagship program, EVerGel, combines exosomes with an innovative hydrogel biomaterial, enabling prolonged release at the site of complex perianal fistulas—a debilitating condition associated with Crohn's disease that affects nearly 2 million patients worldwide. Initial preclinical results are highly promising: in a porcine model close to the human condition, EVerGel achieved complete healing in 87.5% of cases after 4 weeks, compared to just 12.5% in the control group. Thanks to these results, the drug candidate could enter clinical trials as early as 2026, with a target commercialization date for 2030. High potential far beyond the targeted indications Ultimately, the potential of exosome therapies to regenerate tissue and modulate inflammatory processes opens the door to new applications in a variety of fields, including neurodegenerative diseases, age-related disorders, and regenerative cosmetics. In this context, EVerZom has established around twenty global partnerships with players in human health, animal health, and cosmetics. Press contact : Florence Portejoie, FP2COM, 06 07 76 82 83, fportejoie@ About EVerZom Founded in 2019, EVerZom develops exosome-based treatments derived from mesenchymal stem cells, combined with biomaterials for targeted applications. With a proprietary technology for the production and purification of exosomes, EVerZom aims to address unmet medical needs in chronic inflammatory and degenerative diseases. The company relies on cutting-edge scientific expertise, a network of industrial and academic partners, and a development model focused on pharmaceutical quality and industrialization. This €3 million funding is part of the France 2030 plan, a French government initiative endowed with €54 billion to support breakthrough innovations and the emergence of technology champions in strategic sectors such as biotechnology. About France 2030 ✔ Embodies a dual ambition: to sustainably transform key sectors of our economy (health, energy, automotive, aerospace, and space) through technological innovation, and to position France not just as a player but as a leader in the world of tomorrow. From basic research to the emergence of an idea through to the production of a new product or service, France 2030 supports the entire innovation lifecycle up to industrialization. ✔ Is unprecedented in its scope: €54 billion are being invested to help our companies, universities, and research organizations successfully transition in these strategic sectors. The goal is to enable them to competitively tackle ecological and attractiveness challenges and foster the emergence of future leaders in our fields of excellence. France 2030 has two transversal objectives: dedicating 50% of its spending to the decarbonization of the economy and 50% to emerging players carrying innovations that are not harmful to the environment (in line with the Do No Significant Harm principle). ✔ Is implemented collectively: designed and deployed in consultation with economic, academic, local, and European stakeholders to determine strategic orientations and flagship actions. Project leaders are invited to submit their applications through open, rigorous, and selective procedures to benefit from State support. ✔ Is managed by the General Secretariat for Investment on behalf of the Prime Minister and implemented by the French Environment and Energy Management Agency (ADEME), the National Research Agency (ANR), Bpifrance, and the Banque des Territoires. More information: | @SGPI_avenir About the 'Innovations in Biotherapies and Bioproduction' call for projects The 'Innovations in Biotherapies and Bioproduction' call for projects is a support mechanism within the framework of the 'Biotherapies and Bioproduction of Innovative Therapies' acceleration strategy of France 2030, led by the Health Innovation Agency within the General Secretariat for Investment. Its objective is to catalyze and sustain excellence in biotherapy research by accelerating technology transfer and ensuring a constant flow of innovations from bench to bedside. About Bpifrance Bpifrance finances businesses at every stage of their development with loans, guarantees, and equity. It supports their innovation and international projects. Bpifrance also backs their export activities through a broad range of products. Advisory services, training, networking, and acceleration programs for startups, SMEs, and mid-caps are also part of the offering. Thanks to Bpifrance and its 50 regional offices, entrepreneurs benefit from a close, single, and efficient contact to support them and help them meet their challenges. More information: - - Follow us on X (formerly Twitter): @Bpifrance - @BpifrancePresse and on LinkedIn Attachment Everzom_PR_Winner_France_2030_VDEF
Zawya
12-06-2025
- Business
- Zawya
Kumulus Water raises $3.5mln to redefine clean water access with off-grid tech in MENA and Europe
MENA – Kumulus Water, the WaterTech startup transforming air into clean drinking water, has successfully raised $3.5 million in seed funding. The round was led by Bpifrance via France 2030 SGPI and the Île-de-France Region, and included participation from other international regional and investors, such as Plus VC, MENA's most active VC, Khalys Venture, Flat6Labs, Europe's leading bottled water group Spadel, and several family offices and founders from Europe and North Africa. This strategic investment marks a major step in Kumulus' mission to provide decentralized, sustainable drinking water in regions facing water scarcity or lacking reliable infrastructure. Founded in 2021 by Iheb Triki and Mohamed Ali Abid, Kumulus designs and manufactures atmospheric water generators that extract safe drinking water from air humidity, without requiring any existing water or electricity infrastructure. The company's systems are currently in use in schools, hotels, and remote communities across Europe, Africa, and the Middle East. 'We're deeply grateful to our existing and new investors for their trust and continued support,' said Iheb Triki, CEO and Co-founder of Kumulus Water. 'Their involvement is a strong vote of confidence in our technology and our vision. At Kumulus, we believe access to clean drinking water should not depend on existing infrastructure. With this funding, we're taking a major step toward making clean water accessible, sustainable, and decentralized—especially for the communities that need it most.' With this new funding, Kumulus will launch the Kumulus Boks, a new line of industrial-grade, cutting-edge Atmospheric Water Generators (AWG), that provide clean drinking water directly from air humidity, while scaling operations in Tunisia, France, Spain and preparing market entry into Saudi Arabia. Commenting on the fundraising announcement, Hasan Haider, Founder and Managing Partner at +VC said: 'Kumulus is building a scalable, climate-resilient solution to one of the most critical regional and global challenges-access to clean drinking water. At +VC, we invest in founders who are not only mission-driven, solving real-world problems but also executing with commercially scalable solutions. Kumulus fits that profile and is well-positioned for both regional and global growth. We're excited to support their journey as they scale meaningful impact, making them stand out in the climate-tech space.' 'We believe the world needs complementary solutions to address the growing challenge of drinking water scarcity,' added Clément Yvorra, Global Business Development Manager at Spadel. 'What convinced us is Kumulus' ability to produce water locally, without packaging or transportation, offering a truly sustainable alternative.' 'This funding allows us to scale not just production, but impact,' said Mohamed Ali Abid, Co-founder and CTO of Kumulus Water. 'We have spent the past few years refining a technology that can operate reliably in some of the harshest and most water-stressed environments. Now, we are ready to deploy it at scale and bring truly off-grid, sustainable water access to more communities across the region and beyond.' As climate change intensifies and water scarcity deepens, Kumulus offers a resilient, infrastructure-free solution that delivers safe drinking water to even the most remote and arid regions, building not just machines, but long-term climate resilience and empowered communities. Kumulus Water is redefining how clean water is delivered—turning air into drinking water without infrastructure, plastic waste, or grid dependency. By deploying off-grid atmospheric water generators, Kumulus provides a sustainable, decentralized solution for communities facing limited or unreliable access to clean water. About Kumulus Water Kumulus Water is a Paris-based climate-tech startup building atmospheric water generators (AWGs) that transform air into safe, clean drinking water. Designed to operate off-grid and without infrastructure, Kumulus machines are already serving schools, hotels, and communities across Europe, Africa, and the Middle East. For press inquiries, please contact: Neena Punnen neena@ OR For press inquiries, partnership opportunities, please contact: contact@
Yahoo
28-05-2025
- Business
- Yahoo
Bpifrance Acquires a Stake in Arverne Group to Support the Growth of a French Leader in Geothermal Solutions
PAU, France, May 28, 2025--(BUSINESS WIRE)--Regulatory News: Arverne Group (ISIN code : FR001400JWR8, mnemonic code ARVEN), a French industrial company specialized in the production of renewable underground resources, announces that Bpifrance acquires a stake in its capital. Bpifrance acquired 1,709,740 existing Arverne Group shares, representing 4.29% of the share capital and 4.91% of the voting rights, as part of an off-market block sale. This transaction will be accompanied by the appointment of a representative of Bpifrance to the Board of Directors, initially as censor, then as a director, whose appointment will be proposed no later than the first general meeting of Arverne Group shareholders following the combined general meeting of June 18, 2025. Becoming Arverne Group's shareholder is fully in line with Bpifrance's strategy of supporting players in the ecological and energy transition and in the reindustrialisation of France. Convinced of the relevance of its business model, at the heart of the challenges of decarbonisation, energy sovereignty and sovereign supply of critical materials, Bpifrance wishes to support the company in its development. Arverne Group is positioning itself as a major player in the French market for geothermal solutions, by developing two strategic areas: the supply of geothermal heat for its public and private network customers and industrial operators, and an innovative concept for extracting lithium from Alsatian brines, which are rich in this strategic metal for the battery industry. Drilling is the keystone of any activity involving the subsoil, so Arverne Group has developed an integrated model from exploration and drilling to production and sales to end users. As a fast-growing and mission-driven company, the Group's projects contribute to the prosperity of local communities. Pierre Brossollet, Founder and Chairman & CEO of Arverne Group stated : "We are particularly pleased and proud that Bpifrance has become a shareholder in our company. Its commitment to us is a strong endorsement of our vision and strategy. This partnership marks a key stage in Arverne Group's development and will strengthen our ability to deploy our roadmap to reach an annual production capacity of 4 TWh of geothermal heat and 27,000 tons of geothermal lithium by 2031." José Gonzalo, Executive Director, Bpifrance's Development Capital Division, added : "Bpifrance is proud to support Arverne Group in its development, convinced by its strong market potential. This investment is a perfect illustration of Bpifrance's mission: to help innovative players to emerge with sustainable solutions, firmly rooted in the local areas and strategic to France's energy sovereignty and reindustrialisation." Next event: June 18, 2025, Combined General Meeting About Arverne GroupArverne Group specializes in harnessing underground resources to transform them into environmentally friendly, local and renewable energy, contributing to the prosperity of local communities. As an integrated industrial player, Arverne Group spans the entire underground value chain, from exploration to drilling and production to sales to end-users. Arverne Group aims to become the French leader in geothermal energy and its by-products, including low-carbon geothermal lithium. Founded in Pau in 2018, Arverne Group has structured its business activities around several subsidiaries, notably Lithium de France (geothermal heat and extraction and sale of geothermal lithium), 2gré (sale of geothermal heat), Arverne Drilling Services (drilling operations). A mission-driven company, Arverne Group is listed on the Tech Leaders segment of Euronext Paris (ISIN FR001400JWR8, symbol ARVEN). About BpifranceBpifrance's equity investments are operated by Bpifrance Investissement. Bpifrance finances companies - at every stage of their development - through loans, guarantees and equity. Bpifrance supports them in their innovation and international projects. Bpifrance now also supports their export activities through a wide range of products. Advice, universities, networking and acceleration programmes for start-ups, SMEs and ETIs are also part of the services offered to to Bpifrance and its 50 regional offices, entrepreneurs have a single, close and effective contact to help them meet their information : - / - Suivez nous sur LinkedIn : Bpifrance LinkedIn et sur X : @Bpifrance - @BpifrancePresse View source version on Contacts Media Relations: communication@ arvernegroup@ Investor Relations: Bpifrance Sophie 06 30 35 24 71Sophie 07 88 09 28 17 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
28-05-2025
- Business
- Business Wire
Bpifrance Acquires a Stake in Arverne Group to Support the Growth of a French Leader in Geothermal Solutions
PAU, France--(BUSINESS WIRE)--Regulatory News: Arverne Group (ISIN code : FR001400JWR8, mnemonic code ARVEN), a French industrial company specialized in the production of renewable underground resources, announces that Bpifrance acquires a stake in its capital. Bpifrance acquired 1,709,740 existing Arverne Group shares, representing 4.29% of the share capital and 4.91% of the voting rights, as part of an off-market block sale. This transaction will be accompanied by the appointment of a representative of Bpifrance to the Board of Directors, initially as censor, then as a director, whose appointment will be proposed no later than the first general meeting of Arverne Group shareholders following the combined general meeting of June 18, 2025. Becoming Arverne Group's shareholder is fully in line with Bpifrance's strategy of supporting players in the ecological and energy transition and in the reindustrialisation of France. Convinced of the relevance of its business model, at the heart of the challenges of decarbonisation, energy sovereignty and sovereign supply of critical materials, Bpifrance wishes to support the company in its development. Arverne Group is positioning itself as a major player in the French market for geothermal solutions, by developing two strategic areas: the supply of geothermal heat for its public and private network customers and industrial operators, and an innovative concept for extracting lithium from Alsatian brines, which are rich in this strategic metal for the battery industry. Drilling is the keystone of any activity involving the subsoil, so Arverne Group has developed an integrated model from exploration and drilling to production and sales to end users. As a fast-growing and mission-driven company, the Group's projects contribute to the prosperity of local communities. Pierre Brossollet, Founder and Chairman & CEO of Arverne Group stated: ' We are particularly pleased and proud that Bpifrance has become a shareholder in our company. Its commitment to us is a strong endorsement of our vision and strategy. This partnership marks a key stage in Arverne Group's development and will strengthen our ability to deploy our roadmap to reach an annual production capacity of 4 TWh of geothermal heat and 27,000 tons of geothermal lithium by 2031.' José Gonzalo, Executive Director, Bpifrance's Development Capital Division, added : ' Bpifrance is proud to support Arverne Group in its development, convinced by its strong market potential. This investment is a perfect illustration of Bpifrance's mission: to help innovative players to emerge with sustainable solutions, firmly rooted in the local areas and strategic to France's energy sovereignty and reindustrialisation.' Next event: June 18, 2025, Combined General Meeting About Arverne Group Arverne Group specializes in harnessing underground resources to transform them into environmentally friendly, local and renewable energy, contributing to the prosperity of local communities. As an integrated industrial player, Arverne Group spans the entire underground value chain, from exploration to drilling and production to sales to end-users. Arverne Group aims to become the French leader in geothermal energy and its by-products, including low-carbon geothermal lithium. Founded in Pau in 2018, Arverne Group has structured its business activities around several subsidiaries, notably Lithium de France (geothermal heat and extraction and sale of geothermal lithium), 2gré (sale of geothermal heat), Arverne Drilling Services (drilling operations). A mission-driven company, Arverne Group is listed on the Tech Leaders segment of Euronext Paris (ISIN FR001400JWR8, symbol ARVEN). About Bpifrance Bpifrance's equity investments are operated by Bpifrance Investissement. Bpifrance finances companies - at every stage of their development - through loans, guarantees and equity. Bpifrance supports them in their innovation and international projects. Bpifrance now also supports their export activities through a wide range of products. Advice, universities, networking and acceleration programmes for start-ups, SMEs and ETIs are also part of the services offered to entrepreneurs. Thanks to Bpifrance and its 50 regional offices, entrepreneurs have a single, close and effective contact to help them meet their challenges. More information : - / - Suivez nous sur LinkedIn : Bpifrance LinkedIn et sur X : @Bpifrance - @BpifrancePresse
